放射治疗期间的治疗终止:10年的经验
Jason D Nosrati1, Daniel Ma1, Beatrice Bloom1
1Northwell, New Hyde Park, New York; Department of Radiation Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Practical radiation oncology
|July 7, 2024
概括
在放射治疗中,治疗终止 (TT) 在10年内显著下降,从8.49%降至3.02%. 辐射疗法停止率的减少与质量改善举措和根本原因审查有关.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 改善医疗保健质量 改善医疗保健质量
背景情况:
- 放射治疗是癌症治疗的基石.
- 由于各种原因,患者可能过早停止放射治疗.
- 辐射瘤学中治疗终止 (TT) 的发生率和趋势没有得到充分的记录.
研究的目的:
- 在一个大型的多中心放射瘤科,在10年的时间内确定治疗终止 (TT) 的发生率.
- 分析TT病例的趋势,并确定与早期停止治疗相关的常见原因和疾病部位.
主要方法:
- 作为质量和安全计划的一部分,从2013年1月到2023年1月对TT的前性分析.
- TT定义为在启动辐射计划后过早停止治疗.
- 在每月的发病率和死亡率会议上提出的所有TT病例的根本原因分析.
主要成果:
- 总共发生了1448次TT,占31,199次计划辐射课程的4.6%.
- 关税税率从2013年的8.49%下降到2022年的3.02%
- 常见的TT原因包括临终关怀/过期 (35.9%),患者选择 (35.2%) 和临床医生选择 (11.5%),其中中枢神经系统和头癌受影响最大.
结论:
- 观察到TT利率同比显著下降.
- 质量改善举措,包括根本原因审查和每月的案例讨论,可能有助于减少TT.
- 了解和解决TT的原因可以帮助最大限度地减少可预防的治疗中止.
更多相关视频
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.1K
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
相关概念视频
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K